← All patents

US20150011509A1

Compounds and anti-tumor nqo1 substrates

University of Texas System

Abstract

Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Paul J. Hergenrother
Priority date
October 14, 2011
Filing date
October 12, 2012
Publication date
January 08, 2015
Language
en
Metadata fetched
August 29, 2026 00:22